Muhartono, Muhartono and subeki, subeki and Hanriko, Rizki (2019) Mucoxin (Acetogenin) Reduces Proinflammatory Cytokines in Breast Cancer. Biomedical & Pharmacology Journal, 12 (1). ISSN 0974-6242


Download (249kB) | Preview
Official URL:


Mucoxin is a potential compound used as an anticancer agent. Mucoxin induced apoptosis and inhibit proliferation in T47D breast cancer cells line. This study aims to determine the effect of mucoxin on proinflammatory cytokines in breast cancer. Proinflammatorycytokines play important role in the development and metastasis of cancer cells. Breast cancer cell line MCF-7 were grouped into five groups referred to mucoxin doses assays, they are 0 ng/mL; 0,1ng/mL; 0,5 ng/mL; 1 ng/mL; 5 ng/mL with three replication of each. Mucoxin was given for 48 hours. The levels of IL 6 and TNF-α assayed using ELISA methods. The results showed mucoxin decreases IL 6 levels in all treatment doses, but was not significant. Mucoxin also decreases TNF-α levels, with a significant reduction occurring at doses of 1 ng/mL and 5 ng/mL. It is suggested that mucoxin has potent to inhibit proinflammatory cytokines that play a role in the development and metastasis of breast cancer.

Item Type: Article
Subjects: R Medicine > RB Pathology
Divisions: Fakultas Kedokteran (FK) > Prodi Pendidikan Dokter
Depositing User: dr Rizki Hanriko
Date Deposited: 23 May 2019 07:15
Last Modified: 23 May 2019 07:15

Actions (login required)

View Item View Item